| 000 | 01137 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517145129.0 | ||
| 264 | 0 | _c20180509 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/1381612823666170329145053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNikolopoulos, Georgios K | |
| 245 | 0 | 0 |
_aPre-Exposure Prophylaxis for HIV: Evidence and Perspectives. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2017 |
||
| 300 |
_a2579-2591 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
| 650 | 0 | 4 |
_aHIV Infections _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPre-Exposure Prophylaxis _xeconomics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChristaki, Eirini | |
| 700 | 1 | _aParaskevis, Dimitrios | |
| 700 | 1 | _aBonovas, Stefanos | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 23 _gno. 18 _gp. 2579-2591 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612823666170329145053 _zAvailable from publisher's website |
| 999 |
_c27028809 _d27028809 |
||